Treatment outcome and associated factors among epileptic patients at ambulatory clinic of Mettu Karl Comprehensive Specialized Hospital: A cross-sectional study

Objective: The study was aimed to assess the magnitude and associated factors of 2-year seizure-free status of epileptic patients at Mettu Karl Comprehensive Specialized Hospital (MKCSH). Methods: A retrospective cross-sectional study was conducted at MKCSH from 12 February 2020 to 11 August 2020. Treatment outcome was measured in terms of seizure control status and seizure frequency. Accordingly, good treatment outcome was declared if the patients had a 2-year seizure-free status and poor if the patient had episodes of seizure in the last 2 years. The pharmaceutical care network Europe guideline was used to assess the presence of medication-related problems. Multivariable logistic regression was used to analyze the variables by using crude odds ratio (COR) and adjusted odds ratio (AOR) with 95% confidence interval (CI). Finally, the predictors of epilepsy treatment outcome were declared if a P-value was ⩽0.05. Results: Over the study period, more than half of the participants (172 (57.7%)) were males. The median age of participants was 29 and majorly distributed to 18–30 classes. More than one-fourth of the patients were suffering from absent seizure 85 (28.5%) and general tonic-clonic seizure 83 (27.9%). The most commonly prescribed medication was Phenobarbitone which accounts 34 (11.41%), whereas Valproic acid 8 (2.68%) was the least prescribed. Overall, less than half 131 (43.96%) of patients developed poor treatment outcomes. The predictors of treatment outcomes were having head the injury (AOR = 5.7; 95% CI: 3.18, 10.31), family history of epilepsy (AOR = 5.6; 95% CI: 3.07, 10.46) and the presence of drug therapy problems (AOR = 5.2; 95% CI: 2.79, 9.69). Conclusion: The magnitude of poor epilepsy treatment outcome was found to be high. The predictors of epilepsy treatment outcome were the history of head injury, family history of epilepsy and drug therapy problems. Therefore, to improve the treatment outcome of epileptic patients, health care providers should pay close attention to the identified factors. Besides this, the clinical pharmacy service should be implemented to minimize any medication-related problems

[1]  Gebeyaw Biset,et al.  Epilepsy treatment outcomes in the referral hospitals of northeast Ethiopia , 2021, Epilepsy Research.

[2]  Zelalem Belayneh,et al.  A systematic review and meta-analysis of anti-epileptic medication non-adherence among people with epilepsy in Ethiopia , 2020, Archives of Public Health.

[3]  M. Yimam,et al.  Epilepsy Treatment Outcome and Its Predictors among Ambulatory Patients with Epilepsy at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia , 2020, Neurology research international.

[4]  E. Engidawork,et al.  Antiepileptic Drug Treatment Outcomes and Seizure-Related Injuries Among Adult Patients with Epilepsy in a Tertiary Care Hospital in Ethiopia , 2020, Patient related outcome measures.

[5]  Agumas Fentahun Ayalew,et al.  The treatment outcomes of epilepsy and its root causes in children attending at the University of Gondar teaching hospital: A retrospective cohort study, 2018 , 2020, PloS one.

[6]  A. Molla,et al.  Treatment-Seeking Behavior Towards Epilepsy Among Rural Residents in Ethiopia: A Cross-Sectional Study , 2020, Neuropsychiatric disease and treatment.

[7]  Gebre Teklemariam Demoz,et al.  Treatment outcome and associated factors among patients with epilepsy , 2018, Scientific Reports.

[8]  M. Ayalew,et al.  Patient reported adverse events among epileptic patients taking antiepileptic drugs , 2018, SAGE open medicine.

[9]  Patrick Kwan,et al.  Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study , 2017, JAMA neurology.

[10]  E. M. Birru,et al.  Drug therapy of epileptic seizures among adult epileptic outpatients of University of Gondar Referral and Teaching Hospital, Gondar, North West Ethiopia , 2016, Neuropsychiatric disease and treatment.

[11]  B. Uthman,et al.  Epilepsy in Qatar: Causes, treatment, and outcome , 2016, Epilepsy & Behavior.

[12]  Mulugeta Tarekegn Angamo,et al.  Poor treatment outcomes and associated factors among epileptic patients at Ambo Hospital, Ethiopia , 2015 .

[13]  W. Gabr,et al.  Adherence to medication among outpatient adolescents with epilepsy. , 2015, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[14]  Tesfahun Chanie,et al.  Anti-epileptic drug utilization and treatment outcome among epileptic patients on follow-up in a resource poor setting , 2014 .

[15]  Hae-Ra Han,et al.  Psychometric evaluation of hill-bone medication adherence subscale. , 2011, Asian nursing research.

[16]  J. Wheless,et al.  Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians , 2008, Epilepsy & Behavior.

[17]  M. Prevett,et al.  Adherence to treatment in patients with epilepsy: Associations with seizure control and illness beliefs , 2006, Seizure.

[18]  Josemir W Sander,et al.  The Chalfont Seizure Severity Scale. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[19]  D. Greenblatt,et al.  A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.